Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: coachbobknight who wrote (1506)	3/6/2000 9:47:00 AM
From: nigel bates	Read Replies (1) \| Respond to of 4974

HGSI gives the market what it wants - Human Genome Sciences, Inc. (Nasdaq: HGSI - news) announced today that it proposes to make a private offering of $300 million principal amount of Convertible Subordinated Notes Due 2007. The Notes will be convertible into Common Stock, at the option of the holder, at a price to be determined. HGS has granted the initial purchaser of the Notes a 30-day right to purchase an additional $50 million principal of Notes on the same terms and conditions. The Company expects to complete this offering by March 10, 2000 nig